Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × poly ICLC × 30 days × Clear all

Sponsor

Conditions

Smoldering Multiple Myeloma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Melanoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Glioblastoma 1 Fibrolamellar hepatocellular carcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma 1 Anemia, Refractory 1

Interventions

pembrolizumab 14 enfortumab vedotin 10 Specimen Handling 8 Magnetic Resonance Spectroscopy 8 Nivolumab 7 Carboplatin 5 avelumab 4 Ipilimumab 4 Cisplatin 4 Gemcitabine 3 Docetaxel 3 sacituzumab govitecan 2 cabozantinib 2 atezolizumab 2 Paclitaxel 2 CTLA-4 Antigen 2 Biopsy 2 zimberelimab 1 zanidatamab 1 tazemetostat 1 soluble LAG-3 protein, human 1 sargramostim 1 sapanisertib 1 relatlimab 1 regorafenib 1 lenvatinib 1 erdafitinib 1 durvalumab 1 dodecyl maltoside 1 darolutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡